CENTOGENE contributes whole genome analysis to Face2Gene 60 Day Challenge by FDNA

CENTOGENE is proud to contribute to the Face2Gene 60 Day Challenge. This initiative by FDNA was started November 1, 2016. The 60 Day Challenge is a call to clinicians to use Face2Gene to help analyze every patient they see during the next 2 months and thus help the genetics community by improving Face2Gene's learning database, especially in rare disease setting. As a bonus, clinicians will receive genetic testing vouchers - CENTOGENE contributes one whole genome sequencing analysis including detailed medical report (CentoGenome® trio).

Face2Gene is "a suite of phenotyping apps that facilitate comprehensive and precise genetic evaluations". Learn more about Face2 Gene 60 Day challenge here.